<bill session="116" type="s" number="2244" updated="2020-12-28T14:40:11Z">
  <state datetime="2019-07-24">REFERRED</state>
  <status>
    <introduced datetime="2019-07-24"/>
  </status>
  <introduced datetime="2019-07-24"/>
  <titles>
    <title type="official" as="introduced">A bill to amend the Controlled Substances Act to allow community addiction treatment facilities and community mental health facilities to register to dispense controlled substances through the practice of telemedicine, and for other purposes.</title>
    <title type="display">METH Addiction Act</title>
    <title type="short" as="introduced">METH Addiction Act</title>
    <title type="short" as="introduced">Modernizing Eligible Treatment centers for Healing Addiction Act of 2019</title>
  </titles>
  <sponsor bioguide_id="R000307"/>
  <cosponsors/>
  <actions>
    <action datetime="2019-07-24">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-07-24" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="unknown" number="4131"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Health facilities and institutions"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Licensing and registrations"/>
    <term name="Mental health"/>
  </subjects>
  <amendments/>
  <summary date="2019-07-24T04:00:00Z" status="Introduced in Senate">Modernizing Eligible Treatment centers for Healing Addiction Act of 2019 or the METH Addiction Act

This bill directs the Drug Enforcement Administration to register certain community addiction-treatment facilities and community mental-health centers to administer controlled substances via telemedicine.</summary>
  <committee-reports/>
</bill>
